UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

High Complete Remission Rate and Promising Outcome by Combination of Imatinib and Chemotherapy for Newly Diagnosed BCR-ABL–Positive Acute Lymphoblastic Leukemia: A Phase II Study by the Japan Adult Leukemia Study Group

Journal of clinical oncology, 2006-01, Vol.24 (3), p.460-466

2006

Volltextzugriff (PDF)

Proposal of criteria for dyserythropoiesis in the diagnosis of myelodysplastic syndromes

International journal of hematology, 2016-02, Vol.103 (2), p.227-233

2016

Volltextzugriff (PDF)

3. Imatinib Therapy in Chronic Myelogenous Leukemia

Internal Medicine, 2007, Vol.46(2), pp.95-98

Jinnai, Itsuro

2007

Volltextzugriff (PDF)

Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia: the JALSG-ALL97 study

International journal of hematology, 2010-10, Vol.92 (3), p.490-502

2010

Volltextzugriff (PDF)

A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL

International journal of hematology, 2009-06, Vol.89 (5), p.679-688

2009

Volltextzugriff (PDF)

Karyotype at diagnosis is the major prognostic factor predicting relapse-free survival for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib-combined chemotherapy

Haematologica (Roma), 2008-02, Vol.93 (2), p.287-290

2008

Volltextzugriff (PDF)

A novel gene, ANKRD28 on 3p25, is fused with NUP98 on 11p15 in a cryptic 3-way translocation of t(3;5;11 ) (p25;q35;p15) in an adult patient with myelodysplastic syndrome/acute myelogenous leukemia

International journal of hematology, 2007-10, Vol.86 (3), p.238-245

2007

Volltextzugriff (PDF)

Successful treatment with imatinib mesylate in a case of minor BCR-ABL-positive acute myelogenous leukemia

International journal of hematology, 2005-04, Vol.81 (3), p.242-245

2005

Volltextzugriff (PDF)

Promising Outcome of Imatinib-Combined Chemotherapy Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of the Japan Adult Leukemia Study Group (JALSG) Ph+ALL202 Regimen

Blood, 2009-11, Vol.114 (22), p.3090-3090

2009

Volltextzugriff (PDF)

Adhesion-dependent growth of primary adult T cell leukemia cells with down-regulation of HTLV-I p40Tax protein: a novel in vitro model of the growth of acute ATL cells

International journal of hematology, 2008-12, Vol.88 (5), p.551-564

2008

Volltextzugriff (PDF)

Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia

International journal of hematology, 2009-04, Vol.89 (3), p.332-341

2009

Volltextzugriff (PDF)

Membranous nephropathy after allogeneic stem cell transplantation: Report of 2 cases

International journal of hematology, 2004-02, Vol.79 (2), p.193-197

2004

Volltextzugriff (PDF)

Expression of the myeloperoxidase gene in AC133 positive leukemia cells relates to the prognosis of acute myeloid leukemia

Leukemia research, 2006-09, Vol.30 (9), p.1105-1112

2006

Volltextzugriff (PDF)

Combination of intensive chemotherapy and imatinib can rapidly induce high-quality complete remission for a majority of patients with newly diagnosed BCR-ABL–positive acute lymphoblastic leukemia

Blood, 2004-12, Vol.104 (12), p.3507-3512

2004

Volltextzugriff (PDF)

Prospective monitoring of BCR‐ABL1 transcript levels in patients with Philadelphia chromosome‐positive acute lymphoblastic leukaemia undergoing imatinib‐combined chemotherapy

British journal of haematology, 2008-11, Vol.143 (4), p.503-510

2008

Volltextzugriff (PDF)

Prognostic Implication of FLT3 and N-RAS Gene Mutations in Acute Myeloid Leukemia

Blood, 1999-05, Vol.93 (9), p.3074-3080

1999

Volltextzugriff (PDF)

Efficacy and safety of imatinib mesylate for patients in the first chronic phase of chronic myeloid leukemia: Results of a Japanese phase II clinical study

International journal of hematology, 2004-10, Vol.80 (3), p.261-266

2004

Volltextzugriff (PDF)

Difference in clinical features between Japanese and German patients with refractory anemia in myelodysplastic syndromes

Blood, 2005-10, Vol.106 (8), p.2633-2640

2005

Volltextzugriff (PDF)

Acute lymphoblastic leukemia

Nihon rinshō, 2007-01, Vol.65 Suppl 1, p.245

Jinnai, Itsuro

2007

Volltextzugriff (PDF)

Concept and classification of chronic myeloproliferative disorders

Nihon Naika Gakkai zasshi, 2007-07, Vol.96 (7), p.1331-1337

Jinnai, Itsuro

2007

Volltextzugriff (PDF)

1. Concept and Classification of Chronic Myeloproliferative Disorders

Nihon Naika Gakkai Zasshi, 2007, Vol.96(7), pp.1331-1337

Jinnai, Itsuro

2007

Volltextzugriff (PDF)

Correlation between dysplastic lineage and type of cytopenia in myelodysplastic syndromes patients with refractory anemia according to the FAB classification

American journal of clinical pathology, 2013-08, Vol.140 (2), p.253-257

2013

Volltextzugriff (PDF)

Differences in the distribution of subtypes according to the WHO classification 2008 between Japanese and German patients with refractory anemia according to the FAB classification in myelodysplastic syndromes

Leukemia research, 2010-08, Vol.34 (8), p.974-980

2010

Volltextzugriff (PDF)

Treatment of chronic myelogenous leukemia by using imatinib

Nihon Naika Gakkai zasshi, 2005-09, Vol.94 (9), p.1819-1824

Jinnai, Itsuro

2005

Volltextzugriff (PDF)

1 – 25 von 102

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(69)

Publikationsform

Artikel
(102)

Sprache

Englisch
(80)
Japanisch
(24)

Erscheinungsjahr

n.n

Thema

Humans
(77)
Life Sciences & Biomedicine
(52)
Science & Technology
(52)
Male
(51)
Middle Aged
(51)
Hematology
(44)
Female
(42)
Adult
(36)
Biological And Medical Sciences
(35)
Medical Sciences
(35)
Hematologic And Hematopoietic Diseases
(28)
Oncology
(26)
Aged
(25)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(25)
Adolescent
(23)
Aged, 80 And Over
(13)
Benzamides
(13)
Imatinib Mesylate
(13)
Acute Disease
(11)
Bone Marrow - Pathology
(11)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(18)
Rinshō Ketsueki
(17)
Rinsho Ketsueki
(16)
International Journal Of Hematology
(15)
Leukemia Research
(13)
British Journal Of Haematology
(5)
European Journal Of Haematology
(5)
Leukemia
(3)
Nihon Naika Gakkai Zasshi
(3)
Cancer Genetics And Cytogenetics
(2)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

High Complete Remission Rate and Promising Outcome by Combination of Imatinib and Chemotherapy for Newly Diagnosed BCR-ABL–Positive Acute Lymphoblastic Leukemia: A Phase II Study by the Japan Adult Leukemia Study Group

Proposal of criteria for dyserythropoiesis in the diagnosis of myelodysplastic syndromes

3. Imatinib Therapy in Chronic Myelogenous Leukemia

Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia: the JALSG-ALL97 study

A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL

Karyotype at diagnosis is the major prognostic factor predicting relapse-free survival for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib-combined chemotherapy

A novel gene, ANKRD28 on 3p25, is fused with NUP98 on 11p15 in a cryptic 3-way translocation of t(3;5;11 ) (p25;q35;p15) in an adult patient with myelodysplastic syndrome/acute myelogenous leukemia

Successful treatment with imatinib mesylate in a case of minor BCR-ABL-positive acute myelogenous leukemia

Promising Outcome of Imatinib-Combined Chemotherapy Followed by Allogeneic Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of the Japan Adult Leukemia Study Group (JALSG) Ph+ALL202 Regimen

Adhesion-dependent growth of primary adult T cell leukemia cells with down-regulation of HTLV-I p40Tax protein: a novel in vitro model of the growth of acute ATL cells

Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia

Membranous nephropathy after allogeneic stem cell transplantation: Report of 2 cases

Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts

Expression of the myeloperoxidase gene in AC133 positive leukemia cells relates to the prognosis of acute myeloid leukemia

Combination of intensive chemotherapy and imatinib can rapidly induce high-quality complete remission for a majority of patients with newly diagnosed BCR-ABL–positive acute lymphoblastic leukemia

Prospective monitoring of BCR‐ABL1 transcript levels in patients with Philadelphia chromosome‐positive acute lymphoblastic leukaemia undergoing imatinib‐combined chemotherapy

Prognostic Implication of FLT3 and N-RAS Gene Mutations in Acute Myeloid Leukemia

Efficacy and safety of imatinib mesylate for patients in the first chronic phase of chronic myeloid leukemia: Results of a Japanese phase II clinical study

Difference in clinical features between Japanese and German patients with refractory anemia in myelodysplastic syndromes

Acute lymphoblastic leukemia

Concept and classification of chronic myeloproliferative disorders

1. Concept and Classification of Chronic Myeloproliferative Disorders

Correlation between dysplastic lineage and type of cytopenia in myelodysplastic syndromes patients with refractory anemia according to the FAB classification

Differences in the distribution of subtypes according to the WHO classification 2008 between Japanese and German patients with refractory anemia according to the FAB classification in myelodysplastic syndromes

Treatment of chronic myelogenous leukemia by using imatinib

Suchergebnisse filtern